BioCentury | Dec 11, 2008
Distillery Therapeutics

This week in therapeutics

...that inhibiting FHL1 may be useful for protecting against stress-induced cardiac hypertrophy. Cardiac muscles of FHL1-/...
...1 (MAPK1) activation in response to pressure overload-induced cardiac hypertrophy than wild-type controls. The hypertrophic FHL1-/...
...at five weeks than wild-type controls (p<0.05). Next steps could include developing ways to block FHL1's...
Items per page:
1 - 1 of 1